DrugDomain logoDrugDomain

9,9'-{(2R,3R,3aR,5S,7aR,9R,10R,10aR,12S,23R,25aR,27R,28R,28aR,30S,32aR,35aR,37S,39aR)-9-(6-amino-9H-purin-9-yl)-34-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-5,12,23,30,37-pentahydroxy-3,10,28-trimethoxy-5,12,23,30,37-pentaoxidotetracosahydro-2H,7H,25H-trifuro[3,2-f:3',2'-l:3'',2''-x]pyrrolo[3,4-r][1,3,5,9,11,15,17,21,23,27,29,2,4,10,16,22,28]undecaoxazapentaphosphacyclopentatriacontine-2,27-diyl}bis(2-amino-3,9-dihydro-6H-purin-6-one)

Q2QEH4 rRNA N-glycosylase

← Back

ECOD Domain Annotations

ECOD domains from AlphaFold model interacting with ligand C2X

UniProtDrugBankPDB LigandDomain LabelECOD IDX GroupH GroupT GroupF Group
No predicted ECOD data found

ECOD domains from experimental PDB structures interacting with ligand C2X

UniProtDrugBankPDB IDLigand Acc.ChainRes No.Exp. DomainX GroupH GroupT GroupF Group
Q2QEH4n/a3hiwC2XA260e3hiwA1RIP/Polo-box domainRibosome inactivating proteins (RIP)Ribosome inactivating proteins (RIP)RIP
Q2QEH4n/a3hiwC2XA260e3hiwB1RIP/Polo-box domainRibosome inactivating proteins (RIP)Ribosome inactivating proteins (RIP)RIP
Q2QEH4n/a3hiwC2XB260e3hiwA1RIP/Polo-box domainRibosome inactivating proteins (RIP)Ribosome inactivating proteins (RIP)RIP
Q2QEH4n/a3hiwC2XB260e3hiwB1RIP/Polo-box domainRibosome inactivating proteins (RIP)Ribosome inactivating proteins (RIP)RIP